Stock B7E BLUE CAP AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Blue Cap AG Berne S.E.

Equities

B7E

DE000A0JM2M1

Delayed Berne S.E.
Other stock markets
 		5-day change 1st Jan Change
- CHF -.--% Intraday chart for Blue Cap AG -.--% -.--%
06-24 Blue Cap AG Announces Board Changes CI
06-24 Blue Cap AG Approves Dividend CI

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • The stock, which is currently worth 2024 to 0.57 times its sales, is clearly overvalued in comparison with peers.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company is one of the best yield companies with high dividend expectations.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 70.55 times its estimated earnings per share for the ongoing year.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Investment Management & Fund Operators

1st Jan change Capi. Investor Rating ESG Refinitiv
BLUE CAP AG Stock Blue Cap AG
-.--% 93.33M -
EQT AB Stock EQT AB
+9.89% 34.97B
B
PARTNERS GROUP HOLDING AG Stock Partners Group Holding AG
-4.86% 33.36B
B
CVC CAPITAL PARTNERS PLC Stock CVC Capital Partners plc
0.00% 18.83B - -
ONEX CORPORATION Stock Onex Corporation
+0.53% 5.2B -
C
GOLUB CAPITAL BDC, INC. Stock Golub Capital BDC, Inc.
+4.04% 4.14B
D+
CORPORACIÓN FINANCIERA ALBA, S.A. Stock Corporación Financiera Alba, S.A.
+6.25% 3.3B -
B-
PETERSHILL PARTNERS PLC Stock Petershill Partners PLC
+22.94% 2.85B
C-
BRIDGEPOINT GROUP PLC Stock Bridgepoint Group plc
-21.06% 2.21B
C+
INVESTCORP CAPITAL PLC Stock Investcorp Capital plc
+2.51% 1.22B - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. B7E Stock
  4. B7E Stock
  5. Ratings Blue Cap AG